S-1 · primary offering
Issued 2021
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 28 of COGNITION THERAPEUTICS INC's SEC filings and found 1 warrant series, 2 ATM programs, 1 equity line, 3 shelf registrations, 1 S-1 registration and 1 completed offering on file for CGTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 13, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2021
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2022
Total capacity
Sold to date
Issued 2025
Total capacity
Sold to date
Issued 2023
Commitment
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2022
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z